Combinatorial antibody library from multiple sclerosis patients reveals antibodies that cross-react with myelin basic protein and EBV antigen

FASEB Journal

Volumn 25, Issue 12, 2011, Pages 4211-4221

  Gabibov, Alexander G ^a,b   Belogurov Jr , Alexey A ^a,b   Lomakin, Yakov A ^a   Zakharova, Maria Yu ^a   Avakyan, Marat E ^a   Dubrovskaya, Viktorya V ^c   Smirnov, Ivan V ^a   Ivanov, Alexis S ^d   Molnar, Andrey A ^d   Gurtsevitch, Vladimir E ^d   Diduk, Sergey V ^d   Smirnova, Ksenia V ^d   Avalle, Bérangère ^e   Sharanova, Svetlana N ^f   Tramontano, Alfonso ^g   Friboulet, Alain ^e   Boyko, Alexey N ^f   Ponomarenko, Natalia A ^a   Tikunova, Nina V ^c  

^a SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^b INSTITUTE OF GENE BIOLOGY   (Russian Federation)

^c INSTITUTE OF CHEMICAL BIOLOGY AND FUNDAMENTAL MEDICINE   (Russian Federation)

^d INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^e UNIVERSITÉ DE TECHNOLOGIE DE COMPIÈGNE   (France)

^f PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Epstein Barr virus; Latent membrane protein 1; Phage display library

Indexed keywords

AUTOANTIBODY; EPSTEIN BARR VIRUS ANTIGEN; LATENT MEMBRANE PROTEIN 1; MYELIN BASIC PROTEIN; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY;

ANIMAL CELL; ANTIBODY LIBRARY; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; CROSS REACTION; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; LYMPHOCYTE; MOLECULAR MIMICRY; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL;

ADULT; AGED; ANTIBODY DIVERSITY; ANTIGENS, VIRAL; AUTOANTIBODIES; CROSS REACTIONS; HERPESVIRUS 4, HUMAN; HUMANS; MIDDLE AGED; MOLECULAR MIMICRY; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; MYELIN BASIC PROTEINS; PEPTIDE LIBRARY; SINGLE-CHAIN ANTIBODIES; STRUCTURAL HOMOLOGY, PROTEIN; VIRAL MATRIX PROTEINS; YOUNG ADULT;

EID: 82655181512     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.11-190769     Document Type: Article

References (51)

1. Libbey, J. E., and Fujinami, R. S. (2010) Potential triggers of MS. Results Probl. Cell Differ. 51, 21-42
2. Pender, M. P. (2009) Preventing and curing multiple sclerosis by controlling Epstein-Barr virus infection. Autoimmun. Rev. 8, 563-568
3. Reindl, M., Kuenz, B., and Berger, T. (2010) B cells and antibodies in MS. Results Probl. Cell Differ. 51, 99-113
4. Belogurov, A., Jr., Kozyr, A., Ponomarenko, N., and Gabibov, A. (2009) Catalytic antibodies: balancing between Dr. Jekyll and Mr. Hyde. Bioessays 31, 1161-1171
5. Ponomarenko, N. A., Durova, O. M., Vorobiev, I. I., Belogurov, A. A., Jr., Kurkova, I. N., Petrenko, A. G., Telegin, G. B., Suchkov, S. V., Kiselev, S. L., Lagarkova, M. A., Govorun, V. M., Serebryakova, M. V., Avalle, B., Tornatore, P., Karavanov, A., Morse, H. C., 3rd, Thomas, D., Friboulet, A., and Gabibov, A. G. (2006) Autoantibodies to myelin basic protein catalyze site-specific degradation of their antigen. Proc. Natl. Acad. Sci. U. S. A. 103, 281-286 (Pubitemid 43122392)
6. Souza, T. A., Stollar, B. D., Sullivan, J. L., Luzuriaga, K., and Thorley-Lawson, D. A. (2005) Peripheral B cells latently infected with Epstein-Barr virus display molecular hallmarks of classical antigen-selected memory B cells. Proc. Natl. Acad. Sci. U. S. A. 102, 18093-18098 (Pubitemid 41798507)
7. Hikada, M., and Zouali, M. (2010) Multistoried roles for B lymphocytes in autoimmunity. Nat. Immunol. 11, 1065-1068
8. Kabat, E. A., Glusman, M., and Knaub, V. (1948) Quantitative estimation of the albumin and gamma globulin in normal and pathologic cerebrospinal fluid by immunochemical methods. Am. J. Med. 4, 653-662
9. Korn, T., Mitsdoerffer, M., and Kuchroo, V. K. (2010) Immunological basis for the development of tissue inflammation and organ-specific autoimmunity in animal models of multiple sclerosis. Results Probl. Cell Differ. 51, 43-74
10. Ponomarenko, N. A., Durova, O. M., Vorobiev, I. I., Aleksandrova, E. S., Telegin, G. B., Chamborant, O. G., Sidorik, L. L., Suchkov, S. V., Alekberova, Z. S., Gnuchev, N. V., and Gabibov, A. G. (2002) Catalytic antibodies in clinical and experimental pathology: human and mouse models. J. Immunol. Methods 269, 197-211
11. Belogurov, A. A., Jr., Kurkova, I. N., Friboulet, A., Thomas, D., Misikov, V. K., Zakharova, M. Y., Suchkov, S. V., Kotov, S. V., Alehin, A. I., Avalle, B., Souslova, E. A., Morse, H. C., 3rd, Gabibov, A. G., and Ponomarenko, N. A. (2008) Recognition and degradation of myelin basic protein peptides by serum autoantibodies: novel biomarker for multiple sclerosis. J. Immunol. 180, 1258-1267
12. Ponomarenko, N. A., Durova, O. M., Vorobiev, II, Belogurov, A. A., Telegin, G. B., Suchkov, S. V., Misikov, V. K., Morse, H. C., 3rd, and Gabibov, A. G. (2006) Catalytic activity of autoantibodies toward myelin basic protein correlates with the scores on the multiple sclerosis expanded disability status scale. Immunol Lett 103, 45-50 (Pubitemid 43162945)
13. Reindl, M., Khalil, M., and Berger, T. (2006) Antibodies as biological markers for pathophysiological processes in MS. J. Neuroimmunol. 180, 50-62 (Pubitemid 44692320)
14. Chamczuk, A. J., Ursell, M., O'Connor, P., Jackowski, G., and Moscarello, M. A. (2002) A rapid ELISA-based serum assay for myelin basic protein in multiple sclerosis. J. Immunol. Methods 262, 21-27 (Pubitemid 34450727)
15. Kurtzke, J. F. (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33, 1444-1452
16. Hoogenboom, H. R., Griffiths, A. D., Johnson, K. S., Chiswell, D. J., Hudson, P., and Winter, G. (1991) Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains. Nucleic Acids Res. 19, 4133-4137 (Pubitemid 21912784)
17. Vorob'ev, I. I., Ponomarenko, N. A., Durova, O. M., Kozyr, A. V., Demin, A. V., Kolesnikov, A. V., Sashchenko, L. P., Karpeiskii, M., and Gabibov, A. G. (2001) [Structural-functional study of recombinant forms of onconase]. Bioorg. Khim. 27, 257-264
18. Diduk, S. V., Smirnova, K. V., Pavlish, O. A., and Gurtsevitch, V. E. (2008) Functionally significant mutations in the Epstein-Barr virus LMP1 gene and their role in activation of cell signaling pathways. Biochemistry (Mosc.) 73, 1134-1139
19. Pesce, A. J., Apple, R., Sawtell, N., and Michael, J. G. (1986) Cationic antigens. Problems associated with measurement by ELISA. J. Immunol. Methods 87, 21-27 (Pubitemid 16189006)
20. Lamboy, J. A., Tam, P. Y., Lee, L. S., Jackson, P. J., Avrantinis, S. K., Lee, H. J., Corn, R. M., and Weiss, G. A. (2008) Chemical and genetic wrappers for improved phage and RNA display. Chembiochem 9, 2846-2852
21. Yu, X., Gilden, D. H., Ritchie, A. M., Burgoon, M. P., Keays, K. M., and Owens, G. P. (2006) Specificity of recombinant antibodies generated from multiple sclerosis cerebrospinal fluid probed with a random peptide library. J. Neuroimmunol. 172, 121-131 (Pubitemid 43277497)
22. von Budingen, H. C., Harrer, M. D., Kuenzle, S., Meier, M., and Goebels, N. (2008) Clonally expanded plasma cells in the cerebrospinal fluid of MS patients produce myelin-specific antibodies. Eur. J. Immunol. 38, 2014-2023
23. Fang, C. Y., Chiang, C. Y., Pan, Y. R., Tse, K. P., Chang, Y. S., and Chang, H. Y. (2007) Modulation of Epstein-Barr virus latent membrane protein 1 activity by intrabodies. Intervirology 50, 254-263 (Pubitemid 47091842)
24. Maghzi, A. H., Marta, M., Bosca, I., Etemadifar, M., Dobson, R., Maggiore, C., Giovannoni, G., and Meier, U. C. (2011) Viral pathophysiology of multiple sclerosis: A role for Epstein-Barr virus infection? Pathophysiology 18, 13-20
25. Lunemann, J. D., Kamradt, T., Martin, R., and Munz, C. (2007) Epstein-barr virus: environmental trigger of multiple sclerosis? J. Virol. 81, 6777-6784 (Pubitemid 46986614)
26. Thacker, E. L., Mirzaei, F., and Ascherio, A. (2006) Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis. Ann. Neurol. 59, 499-503 (Pubitemid 43358070)
27. Haahr, S., Plesner, A. M., Vestergaard, B. F., and Hollsberg, P. (2004) A role of late Epstein-Barr virus infection in multiple sclerosis. Acta Neurol. Scand. 109, 270-275 (Pubitemid 38406503)
28. Yu, X., Gilden, D., Schambers, L., Barmina, O., Burgoon, M., Bennett, J., and Owens, G. (2010) Peptide reactivity between multiple sclerosis (MS) CSF IgG and recombinant antibodies generated from clonally expanded plasma cells in MS CSF. J. Neuroimmunol. 233, 192-203
29. Xiao, B. G., Linington, C., and Link, H. (1991) Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls. J. Neuroimmunol. 31, 91-96
30. Zhang, Y., Da, R. R., Guo, W., Ren, H. M., Hilgenberg, L. G., Sobel, R. A., Tourtellotte, W. W., Smith, M. A., Olek, M., Gupta, S., Robertson, R. T., Nagra, R., Van Den Noort, S., and Qin, Y. (2005) Axon reactive B cells clonally expanded in the cerebrospinal fluid of patients with multiple sclerosis. J. Clin. Immunol. 25, 254-264 (Pubitemid 40884052)
31. Lambracht-Washington, D., O'Connor, K. C., Cameron, E. M., Jowdry, A., Ward, E. S., Frohman, E., Racke, M. K., and Monson, N. L. (2007) Antigen specificity of clonally expanded and receptor edited cerebrospinal fluid B cells from patients with relapsing remitting MS. J. Neuroimmunol. 186, 164-176 (Pubitemid 46770863)
32. Jafari, N., van Nierop, G. P., Verjans, G. M., Osterhaus, A. D., Middeldorp, J. M., and Hintzen, R. Q. (2010) No evidence for intrathecal IgG synthesis to Epstein Barr virus nuclear antigen-1 in multiple sclerosis. J. Clin. Virol. 49, 26-31
33. Hauser, S. L., and Oksenberg, J. R. (2006) The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron 52, 61-76 (Pubitemid 44466355)
34. Ascherio, A., and Munger, K. L. (2007) Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann. Neurol. 61, 288-299 (Pubitemid 46676728)
35. Fraser, K. B., Haire, M., Millar, J. H., and McCrea, S. (1979) Increased tendency to spontaneous in-vitro lymphocyte transformation in clinically active multiple sclerosis. Lancet 2, 175-176
36. Sumaya, C. V., Myers, L. W., and Ellison, G. W. (1980) Epstein-Barr virus antibodies in multiple sclerosis. Arch. Neurol. 37, 94-96 (Pubitemid 10174389)
37. Lindsey, J. W., Hatfield, L. M., and Vu, T. (2010) Epstein-Barr virus neutralizing and early antigen antibodies in multiple sclerosis. Eur. J. Neurol. 17, 1263-1269
38. Levin, L. I., Munger, K. L., O'Reilly, E. J., Falk, K. I., and Ascherio, A. (2010) Primary infection with the Epstein-Barr virus and risk of multiple sclerosis. Ann. Neurol. 67, 824-830
39. Pender, M. P., and Greer, J. M. (2007) Immunology of multiple sclerosis. Curr. Allergy Asthma Rep. 7, 285-292 (Pubitemid 46958746)
40. Nociti, V., Frisullo, G., Marti, A., Luigetti, M., Iorio, R., Patanella, A. K., Bianco, A., Tonali, P. A., Grillo, R. L., Sabatelli, M., and Batocchi, A. P. (2010) Epstein-Barr virus antibodies in serum and cerebrospinal fluid from multiple sclerosis, chronic inflammatory demyelinating polyradiculoneuropathy and amyotrophic lateral sclerosis. J. Neuroimmunol. 225, 149-152
41. Jaquiery, E., Jilek, S., Schluep, M., Meylan, P., Lysandropoulos, A., Pantaleo, G., and Du Pasquier, R. A. (2010) Intrathecal immune responses to EBV in early MS. Eur. J. Immunol. 40, 878-887
42. Serafini, B., Rosicarelli, B., Franciotta, D., Magliozzi, R., Reynolds, R., Cinque, P., Andreoni, L., Trivedi, P., Salvetti, M., Faggioni, A., and Aloisi, F. (2007) Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J. Exp. Med. 204, 2899-2912 (Pubitemid 350179559)
43. Lunemann, J. D., and Munz, C. (2009) EBV in MS: guilty by association? Trends Immunol. 30, 243-248
44. Farrell, R. A., Antony, D., Wall, G. R., Clark, D. A., Fisniku, L., Swanton, J., Khaleeli, Z., Schmierer, K., Miller, D. H., and Giovannoni, G. (2009) Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI. Neurology 73, 32-38
45. Cepok, S., Zhou, D., Srivastava, R., Nessler, S., Stei, S., Bussow, K., Sommer, N., and Hemmer, B. (2005) Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis. J. Clin. Invest. 115, 1352-1360 (Pubitemid 40629055)
46. Sawcer, S., Ban, M., Wason, J., and Dudbridge, F. (2010) What role for genetics in the prediction of multiple sclerosis? Ann. Neurol. 67, 3-10
47. Meij, P., Vervoort, M. B., Bloemena, E., Schouten, T. E., Schwartz, C., Grufferman, S., Ambinder, R. F., and Middeldorp, J. M. (2002) Antibody responses to Epstein-Barr virus-encoded latent membrane protein-1 (LMP1) and expression of LMP1 in juvenile Hodgkin's disease. J. Med. Virol. 68, 370-377
48. Meij, P., Leen, A., Rickinson, A. B., Verkoeijen, S., Vervoort, M. B., Bloemena, E., and Middeldorp, J. M. (2002) Identification and prevalence of CD8(+) T-cell responses directed against Epstein-Barr virus-encoded latent membrane protein 1 and latent membrane protein 2. Int. J. Cancer 99, 93-99 (Pubitemid 34273204)
49. Meij, P., Vervoort, M. B., Aarbiou, J., van Dissel, P., Brink, A., Bloemena, E., Meijer, C. J., and Middeldorp, J. M. (1999) Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases. J. Infect. Dis. 179, 1108-1115 (Pubitemid 29196489)
50. Lycke, J., Svennerholm, B., Hjelmquist, E., Frisen, L., Badr, G., Andersson, M., Vahlne, A., and Andersen, O. (1996) Acyclovir treatment of relapsing-remitting multiple sclerosis. A randomized, placebo-controlled, double-blind study. J. Neurol. 243, 214-224
51. Stepanov, A. V., Belogurov, A. A., Jr., Ponomarenko, N. A., Stremovskiy, O. A., Kozlov, L. V., Bichucher, A. M., Dmitriev, S. E., Smirnov, I. V., Shamborant, O. G., Balabashin, D. S., Sashchenko, L. P., Tonevitsky, A. G., Friboulet, A., Gabibov, A. G., and Deyev, S. M. (2011) Design of targeted B cell killing agents. PLoS One 6, e20991